- Off-label — written informed consent
- Transparent pricing, quoted in writing
Coverage & Cost
Private Pay (Off-Label HBOT)
What OHIP Covers
When Private Pay Applies
Private-pay HBOT at Evolve is offered for off-label indications — conditions with a biologically defensible rationale for hyperbaric oxygen but which are not on the OHIP-covered list and are not authorized by WSIB. Examples include post-concussive symptoms, long COVID, certain orthopedic non-union scenarios, and select gastrointestinal conditions.
Responsible Use
Our Approach to Off-Label Use
Evolve follows a conservative, evidence-anchored approach to off-label HBOT. Before recommending private-pay treatment for any off-label condition, we:
- Review the patient’s diagnosis, prior treatment, and current symptoms with the consulting hyperbaric physician
- Discuss the published evidence base honestly — including where evidence is mixed, limited, or absent
- Confirm there are no contraindications to HBOT
- Provide a written informed consent document acknowledging off-label use and realistic expected outcomes
- Quote the total expected cost in writing before any treatment begins
Pricing
Cost and Pricing
We do not display per-session pricing publicly. Pricing depends on:
- The indication and the recommended number of sessions
- Whether the treatment is at standard pressure (typically 2.0–2.4 ATA) or modified protocol
- Whether any additional services (e.g., follow-up imaging review) are included
After consultation, you will receive a written cost estimate covering the entire recommended treatment course. You will not be asked to pay or commit before this estimate is in your hand.
Payment
Payment & Refund Policy
- Payment is collected per session or as a prepaid block, depending on the treatment course
- Refunds are available for sessions not yet delivered if treatment is discontinued for clinical reasons or patient choice
- We do not offer refunds for sessions already delivered, regardless of outcome — consistent with how all medical services operate
What private pay does not include:
- Diagnostic imaging or laboratory tests outside the scope of the HBOT consultation
- Specialty consultations from outside physicians
- Pharmacy or wound-care supplies used outside the clinic visit
Reimbursement
Insurance Reimbursement
After Private Pay
Patients sometimes recover part of private-pay costs through their extended health benefits. We provide itemized receipts and a letter of medical necessity to support such claims. However, reimbursement is determined by your insurer; we do not promise or guarantee any particular outcome from a private insurance submission.
Off-Label / Investigational Use Disclosure
The use of Hyperbaric Oxygen Therapy (HBOT) for these conditions is not currently listed by the Undersea and Hyperbaric Medical Society (UHMS) as a standard-of-care indication, and it is not covered by OHIP. It is considered an investigational or off-label use.
Patients pursuing treatment do so on a private-pay basis after a physician-supervised assessment and written informed consent. Evolve Hyperbarics does not represent or imply that HBOT will cure, reverse, or guarantee improvement of these conditions. Individual outcomes vary.
All off-label HBOT at Evolve Hyperbarics is delivered under the supervision of a CPSO-registered physician with hyperbaric training, with reference to published peer-reviewed literature where available.
We will recommend against treatment when evidence does not support it
If your condition does not have a biologically defensible rationale for HBOT, or if available evidence does not support a meaningful expected benefit, we will tell you so plainly. Treatment we do not believe is in your interest is treatment we will not provide.
References
- College of Physicians and Surgeons of Ontario. Policy Statement: Consent to Treatment. CPSO Policy #3-15.
- College of Physicians and Surgeons of Ontario. Policy Statement: Off-Label Use of Drugs and Devices. CPSO Policy #3-16.
- Mathieu D, Marroni A, Kot J. Tenth European Consensus Conference on Hyperbaric Medicine. Diving Hyperb Med. 2017;47(1):24-32.
Medical review
Dr. Vik Agarwal MD CCFP FRCPC CAQ-HP — President, Evolve Medical Group
Dr. Seema Agarwal MD CCFP CAQ-HP — Chief Medical Officer, Evolve Hyperbarics
Last reviewed: May 2026 · Next: May 2027
Get Started
Find Out if Your Treatment Is OHIP-Covered
Call 1-888-851-4268 to speak with our team, or use the eligibility form — we confirm OHIP
coverage at consultation and handle all the documentation. We typically respond within one business day.